Merck Sharp & Dohme LLC (MSD) is a biopharmaceutical company with more than 130 years of history in developing medicines, vaccines, and veterinary health solutions. Its work spans human health - from infectious disease to oncology - as well as animal health, public health, food safety, and agriculture. The company operates globally, with a presence across the United States, Canada, and markets worldwide.
MSD's technology footprint is broad. Its research pipeline covers drug discovery, clinical development, and vaccine science, and the company describes its current pipeline as one of the most diverse in its history. On the animal health side, its MSD Animal Health division develops veterinary solutions that intersect with food safety and global protein supply, in addition to companion animal care. The company's scientific legacy includes contributions such as Streptomycin, which helped reduce tuberculosis deaths by nearly 50% by 1950.
Across its technical domains - biopharmaceutical research, medicine and vaccine development, veterinary medicine, and pipeline drug development - MSD applies research-led methods to address serious diseases in both people and animals. The company has stated a guiding philosophy that medicine exists for patients rather than profit, and that scientific direction is determined by where the greatest difference can be made.
